Literature DB >> 28314981

Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population.

Nadia Arshad1, Trond Isaksen2,3, John-Bjarne Hansen2,3, Sigrid K Brækkan2,3.   

Abstract

Changes in the incidence of venous thromboembolism (VTE) during the last two decades have not been extensively studied. Therefore, we studied time trends in the incidence rates (IRs) of deep vein thrombosis (DVT) and pulmonary embolism (PE) in a cohort of 26,855 subjects, aged 25-97 years, enrolled in the Tromsø study in 1994/1995. The subject were followed-up throughout 2012, and all symptomatic, objectively confirmed, incident VTEs were identified using multiple sources (hospital discharge-, radiology procedure- and autopsy registry) and validated by review of medical records. Age-adjusted biennial IR per 100,000 person years (PY) with 95% confidence intervals (CI) were calculated using Poisson regression. Between January 1996 and December 2012, 693 VTEs occurred during 368,150 PY of follow up. The IR of VTE increased from 158 (95% CI 116-199) in 1996/1997 to 201 (95% CI 160-243) in 2010/2011. There was a marked increase in the rates of PE (with/without concurrent DVT) ranging from 45 (95% CI 23-67) in 1996/1997 to 113 (95% CI 82-144) in 2010/2011, whereas the rates of isolated DVT decreased (112, 95% CI 77-146 in 1996/1997 and 88, 95% CI 61-115 in 2010/2011). Despite advances in prophylaxis, the IR of VTE has increased slightly during the last 15 years, mainly due to an increase in PE. Although the introduction of better diagnostic tools to some extent may explain the increase in PE rates, our findings suggest that there is still a need for improvement in risk factor management and prevention strategies of first time VTE.

Entities:  

Keywords:  Deep vein thrombosis; Incidence; Pulmonary embolism; Venous thromboembolism

Mesh:

Year:  2017        PMID: 28314981     DOI: 10.1007/s10654-017-0238-y

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  27 in total

1.  Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism.

Authors:  Robert J Glynn; Bernard Rosner
Journal:  Am J Epidemiol       Date:  2005-10-05       Impact factor: 4.897

2.  Time trends in pulmonary embolism in the United States: evidence of overdiagnosis.

Authors:  Renda Soylemez Wiener; Lisa M Schwartz; Steven Woloshin
Journal:  Arch Intern Med       Date:  2011-05-09

Review 3.  Epidemiology and risk factors for venous thrombosis.

Authors:  Mary Cushman
Journal:  Semin Hematol       Date:  2007-04       Impact factor: 3.851

4.  Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009).

Authors:  Wei Huang; Robert J Goldberg; Frederick A Anderson; Catarina I Kiefe; Frederick A Spencer
Journal:  Am J Med       Date:  2014-05-06       Impact factor: 4.965

Review 5.  Venous thromboembolism: disease burden, outcomes and risk factors.

Authors:  J A Heit
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

6.  Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study.

Authors:  Frederick A Spencer; Cathy Emery; Samuel W Joffe; Luigi Pacifico; Darleen Lessard; George Reed; Joel M Gore; Robert J Goldberg
Journal:  J Thromb Thrombolysis       Date:  2009-11       Impact factor: 2.300

7.  Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS).

Authors:  Nazim Isma; Peter J Svensson; Anders Gottsäter; Bengt Lindblad
Journal:  Thromb Res       Date:  2009-06-03       Impact factor: 3.944

8.  The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly.

Authors:  W D Kniffin; J A Baron; J Barrett; J D Birkmeyer; F A Anderson
Journal:  Arch Intern Med       Date:  1994-04-25

9.  Cardiovascular disease in Europe--epidemiological update 2015.

Authors:  Nick Townsend; Melanie Nichols; Peter Scarborough; Mike Rayner
Journal:  Eur Heart J       Date:  2015-08-25       Impact factor: 29.983

Review 10.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

View more
  20 in total

1.  The impact of co-morbidity on the disease burden of VTE.

Authors:  Sonja Kroep; Ling-Hsiang Chuang; Alexander Cohen; Pearl Gumbs; Ben van Hout; Manuel Monreal; Stefan N Willich; Anselm Gitt; Rupert Bauersachs; Giancarlo Agnelli
Journal:  J Thromb Thrombolysis       Date:  2018-11       Impact factor: 2.300

2.  Plasma hepcidin is associated with future risk of venous thromboembolism.

Authors:  Trygve S Ellingsen; Jostein Lappegård; Thor Ueland; Pål Aukrust; Sigrid K Brækkan; John-Bjarne Hansen
Journal:  Blood Adv       Date:  2018-06-12

Review 3.  Progress in the research on venous thromboembolism.

Authors:  Zhen Zhang; Liang Tang; Yu Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

4.  Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism.

Authors:  Magnus S Edvardsen; Kristian Hindberg; Ellen-Sofie Hansen; Vânia M Morelli; Thor Ueland; Pål Aukrust; Sigrid K Brækkan; Line H Evensen; John-Bjarne Hansen
Journal:  Blood Adv       Date:  2021-01-12

5.  A large-scale exome array analysis of venous thromboembolism.

Authors:  Sara Lindström; Jennifer A Brody; Constance Turman; Marine Germain; Traci M Bartz; Erin N Smith; Ming-Huei Chen; Marja Puurunen; Daniel Chasman; Jeffrey Hassler; Nathan Pankratz; Saonli Basu; Weihua Guan; Beata Gyorgy; Manal Ibrahim; Jean-Philippe Empana; Robert Olaso; Rebecca Jackson; Sigrid K Braekkan; Barbara McKnight; Jean-Francois Deleuze; Cristopher J O'Donnell; Xavier Jouven; Kelly A Frazer; Bruce M Psaty; Kerri L Wiggins; Kent Taylor; Alexander P Reiner; Susan R Heckbert; Charles Kooperberg; Paul Ridker; John-Bjarne Hansen; Weihong Tang; Andrew D Johnson; Pierre-Emmanuel Morange; David A Trégouët; Peter Kraft; Nicholas L Smith; Christopher Kabrhel
Journal:  Genet Epidemiol       Date:  2019-01-19       Impact factor: 2.344

6.  Incidence and risk factors of preoperative deep venous thrombosis following hip fracture: a retrospective analysis of 293 consecutive patients.

Authors:  Si-Ying He; Ping Zhang; Han-Jun Qin; Nan Jiang; Bin Yu
Journal:  Eur J Trauma Emerg Surg       Date:  2022-01-22       Impact factor: 2.374

7.  C-reactive protein and risk of venous thromboembolism: results from a population-based case-crossover study.

Authors:  Gro Grimnes; Trond Isaksen; Ynse Ieuwe Gerardus Vladimir Tichelaar; Jan Brox; Sigrid Kufaas Brækkan; John-Bjarne Hansen
Journal:  Haematologica       Date:  2018-04-19       Impact factor: 9.941

8.  Dietary intake of marine n-3 polyunsaturated fatty acids and future risk of venous thromboembolism.

Authors:  Trond Isaksen; Line H Evensen; Stein Harald Johnsen; Bjarne K Jacobsen; Kristian Hindberg; Sigrid K Brækkan; John-Bjarne Hansen
Journal:  Res Pract Thromb Haemost       Date:  2018-12-13

9.  Current and future burden of venous thrombosis: Not simply predictable.

Authors:  Luuk J J Scheres; Willem M Lijfering; Suzanne C Cannegieter
Journal:  Res Pract Thromb Haemost       Date:  2018-04-17

Review 10.  Resolution of Deep Venous Thrombosis: Proposed Immune Paradigms.

Authors:  J Matthew Nicklas; Aviva E Gordon; Peter K Henke
Journal:  Int J Mol Sci       Date:  2020-03-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.